World's Best Scientists 2026 revealed!
Danuta M. Skowronski

Danuta M. Skowronski

D-Index & Metrics

Immunology

D-Index
62
Citations
18811
World Ranking
3102
National Ranking
74

Overview

Danuta M. Skowronski is affiliated with the University of British Columbia in Canada and has contributed extensively to the field of medicine, with a focus on infectious diseases and epidemiology. Their research primarily addresses respiratory viral infections, particularly SARS-CoV-2 and influenza viruses.

The scientist's work spans several interconnected topics including:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Influenza Virus Research Studies
  • Respiratory viral infections research
  • Viral gastroenteritis research and epidemiology
  • Vaccine Coverage and Hesitancy
  • SARS-CoV-2 detection and testing

Skowronski has published in key venues that repeatedly feature their research, such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Infectious Diseases
  • Eurosurveillance
  • The Journal of Infectious Diseases
  • Open Forum Infectious Diseases

Frequent co-authors include:

  • Gaston De Serres
  • Sara Carazo
  • Denis Talbot
  • Agatha N. Jassem
  • Nicholas Brousseau

Notable recent publications authored or co-authored by Skowronski demonstrate an emphasis on vaccine effectiveness and epidemiological assessments, including:

  • Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada (2022), Clinical Infectious Diseases
  • Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, Canada (2022), Canadian Medical Association Journal
  • Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British Columbia and Quebec, Canada (2021), bioRxiv (Cold Spring Harbor Laboratory)
  • 2023/24 mid-season influenza and Omicron XBB.1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN) (2024), Eurosurveillance

Best Publications

  • The Genome Sequence of the SARS-associated Coronavirus

    Marco A. Marra;Steven J. M. Jones;Caroline R. Astell;Robert A. Holt

  • Identification of Severe Acute Respiratory Syndrome in Canada

    Susan M. Poutanen;Susan M. Poutanen;Donald E. Low;Bonnie Henry;Sandy Finkelstein

  • Network theory and SARS: predicting outbreak diversity.

    Lauren Ancel Meyers;Babak Pourbohloul;M. E.J. Newman;M. E.J. Newman;Danuta M. Skowronski

  • Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

    Danuta M Skowronski;Gaston De Serres

  • Human illness from avian influenza H7N3, British Columbia.

    S. Aleina Tweed;Danuta M. Skowronski;Samara T. David;Andrew Larder

  • Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses

    Danuta M. Skowronski;Naveed Z. Janjua;Gaston De Serres;Suzana Sabaiduc

  • Epidemiology of pertussis.

    Tina Quanbee Tan;Evelinda Trindade;Danuta Skowronski

  • Association between the 2008–09 Seasonal Influenza Vaccine and Pandemic H1N1 Illness during Spring–Summer 2009: Four Observational Studies from Canada

    Danuta M. Skowronski;Gaston De Serres;Natasha S. Crowcroft;Naveed Z. Janjua

  • Repeated annual influenza vaccination and vaccine effectiveness: review of evidence

    Edward A. Belongia;Danuta M. Skowronski;Huong Q. McLean;Catharine Chambers

  • The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials.

    G De Serres;D M Skowronski;X W Wu;C S Ambrose

  • Novel avian influenza H7N3 strain outbreak, British Columbia

    Martin Hirst;Caroline R Astell;Malachi Griffith;Shaun M. Coughlin

  • Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.

    D.M. Skowronski;C. Masaro;T.L. Kwindt;A. Mak

  • The changing age and seasonal profile of pertussis in Canada

    Danuta M. Skowronski;Gaston De Serres;Diane MacDonald;Diane MacDonald;Wrency Wu

  • A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014–2015 Season

    Danuta M. Skowronski;Catharine Chambers;Suzana Sabaiduc;Gaston De Serres

  • Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada

    Unknown

  • Rapid Decline of Influenza Vaccine—Induced Antibody in the Elderly: Is It Real, or Is It Relevant?

    Danuta M. Skowronski;S. Aleina Tweed;Gaston De Serres

  • Severe Acute Respiratory Syndrome (SARS): A Year in Review

    Danuta M. Skowronski;Caroline Astell;Robert C. Brunham;Donald E. Low

  • An Outbreak of Human Coronavirus OC43 Infection and Serological Cross-reactivity with SARS Coronavirus

    David M Patrick;Martin Petric;Danuta M Skowronski;Roland Guasparini

  • Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010–2011 to 2014–2015

    Danuta M. Skowronski;Catharine Chambers;Gaston De Serres;Suzana Sabaiduc

  • Initial human transmission dynamics of the pandemic (H1N1) 2009 virus in North America.

    Babak Pourbohloul;Armando Ahued;Bahman Davoudi;Rafael Meza

  • Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus.

    Raymond H. See;Alexander N. Zakhartchouk;Martin Petric;David J. Lawrence

Frequent Co-Authors

Gaston De Serres
Gaston De Serres Université Laval
Yan Li
Yan Li Public Health Agency of Canada
Martin Petric
Martin Petric University of British Columbia
Mel Krajden
Mel Krajden University of British Columbia
Hugues Charest
Hugues Charest University of Montreal
Nathalie Bastien
Nathalie Bastien Public Health Agency of Canada
Jonathan B. Gubbay
Jonathan B. Gubbay BC Children's Hospital Foundation
Robert C. Brunham
Robert C. Brunham University of British Columbia
Steven J. Drews
Steven J. Drews Canadian Blood Services
Guy Boivin
Guy Boivin Université Laval

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding your education through complementary healthcare programs can open diverse career opportunities. Many students explore practical nursing as a stepping stone, and identifying lpn schools easy to get into can be a strategic way to begin a healthcare career with manageable admissions requirements.

Advancing further, becoming a Family Nurse Practitioner (FNP) offers a broader scope of practice. When selecting a program, it’s helpful to consider the easiest fnp program options to ensure timely and efficient progression toward certification.

For those drawn to mental health, Psychiatric-Mental Health Nurse Practitioner (PMHNP) programs blend clinical expertise with psychological care. If clinical experience placement is vital, checking the best online pmhnp programs can guide candidates to reputable programs with strong practicum support.

Cost is another significant factor. Finding affordable educational paths like the cheapest psych np programs ensures you can pursue your goals without overwhelming financial burden.

Best Scientists Citing Danuta M. Skowronski

Trending Scientists

Recently Published Articles